Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,665 across all filing types
Latest filing 2015-03-25 Director's Dealing
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 2 pages 250.7KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including number of shares/options held before and after the change, nature of the change, and dates. This is a report of personal share transactions by a company director, which fits the definition of Director's Dealing filings. The document length is 3712 characters, which is consistent with a detailed notice rather than a brief announcement. There is no indication this is an annual report, audit report, or any other category. Therefore, the correct classification is Director's Dealing (DIRS).
2015-03-25 English
Appendix 3B - Placement & Exercise of Options 14 pages 805.7KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form submitted to the Australian Stock Exchange (ASX), which is a standard form used to announce new issues of securities, including private placements and exercise of options. It details the number and class of securities issued, issue price, purpose, and compliance with ASX listing rules. The document is a regulatory announcement about capital raising and share allotment, not a financial report or earnings release. It is not a full financial report but a formal notification of capital changes and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement but a full regulatory filing about capital changes.
2015-03-24 English
Letter to Optionholders 4 pages 330.5KB
Capital/Financing Update Classification · 95% confidence The document is a letter dated 19 March 2015 addressed to optionholders of Admedus Ltd regarding a non-renounceable entitlement offer. It details the terms of the offer, the timetable, use of funds, and instructions for participation. The content focuses on informing shareholders and optionholders about the rights issue and how to exercise options to participate. There are no financial statements or detailed financial analysis present, only an announcement and explanation of a capital raising event. The document length is 7391 characters, which is relatively short and consistent with an announcement rather than a full report. The key indicators such as 'Entitlement Offer', 'Offer Document', 'non-renounceable pro-rata entitlement offer', and the detailed timetable for the offer point to a capital or financing update. Therefore, the document should be classified as a Capital/Financing Update (CAP).
2015-03-19 English
Letter to Eligible Shareholders 4 pages 261.4KB
Capital/Financing Update Classification · 95% confidence The document is a notice to shareholders regarding a non-renounceable pro-rata entitlement offer (rights issue) to raise capital. It details the terms of the offer, the purpose of the funds to be raised, the indicative timetable, and the capital structure post-offer. It references an Offer Document that will be lodged with the ASX and made available to shareholders, but this document itself is a notification letter about the entitlement offer, not the offer document or a financial report. The content focuses on capital raising activities and share issuance. Therefore, this is best classified as a Capital/Financing Update (CAP). The document length (7901 characters) and detailed content support it being more than a brief announcement but not a full financial report or regulatory filing. Hence, the classification is CAP with high confidence.
2015-03-19 English
Letter to Ineligible Shareholders 1 page 79.8KB
Capital/Financing Update Classification · 100% confidence The document is a letter dated 19 March 2015 from Admedus Ltd to shareholders regarding a non-renounceable rights issue. It describes the terms of the entitlement offer, including the issue price, ratio, and eligible shareholders. The document is an announcement of a capital raising activity, specifically a rights issue, and does not contain financial statements or detailed financial analysis. The length is short (2102 characters), and it is clearly a shareholder communication about a financing event. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2015-03-19 English
Non-Renounceable Right Issue Offer Document 28 pages 549.1KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'OFFER DOCUMENT' and describes a non-renounceable pro rata offer of new shares at a specified issue price, including details about the offer, eligibility, timetable, and use of proceeds. It references section 708AA of the Corporations Act 2001 (Cth) and is clearly an offer to existing shareholders to subscribe for new shares. The content focuses on the terms and conditions of the share offer, the rights attaching to the new shares, and instructions for shareholders to participate. This matches the definition of a Share Issue/Capital Change announcement, which covers new share issues and related capital changes. The document is not a full financial report, earnings release, or regulatory filing, but a detailed offer document for a capital raising event.
2015-03-19 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.